A phase 4 clinical study to compare the safety and efficacy of LONQUEX® with NEULASTA® and Placebo in patients with Non-Small-Cell Lung Cancer treated with first-line chemotherapy

Update Il y a 4 ans
Reference: EUCTR2014-005096-85

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To collect comparative data for LONQUEX®, Neulasta® and placebo in patients with advanced squamous or non-squamous NSCLC Stage IIIB/IV, including full details of disease progression (whether or not leading to death) and mortality, for detailed clinical review.


Inclusion criteria

  • Advanced squamous or non-squamous non-small-cell lung cancer (NSCLC) Stage IIIB/IV